FundingWatcher
Home / Startups / Top health care startups / Health care startups that raised Series B / Health care startups that raised Series B in DACH

Health care startups that raised Series B in DACH

Updated 16 Nov 2026

Reset
Health care startups that raised Series B in DACH
One-time CSV
  • 103 funded companies, 65 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-health-care--series-b~dach.csv103 rows × 18 columns
CompanyCityLast roundAmountDate
Laza MedicalPfaffikonSeries B$160.0M2026-11-04
NovaGo TherapeuticsSchlierenSeries B$29.7M2026-08-31
Vaderis TherapeuticsBaselSeries B$152.0M2026-08-11
NVision Quantum TechnologiesUlmSeries B$38.0M2026-05-13
Windward BioBaselSeries B$165.0M2026-05-04
ExcivaHeidelbergSeries B$59.4M2026-01-20
GlycoEraWädenswilSeries B$130.0M2025-05-27
ClinomicAachenSeries B$25.3M2025-04-08

8 rows of the CSV in 5 of its 18 columns.

103
Startups
$3.4B
Total raised
11
Funded in the last 12 months
$743.3M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

30 of 103
30 rows
Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
Laza Medical Laza Medical produces AI-powered robotic imaging systems for cardiovascular treatments. Artificial intelligence Pfaffikon, Switzerland Series B $160.0M 2026-11-04 $196.0M Page One Ventures, Unorthodox Ventures, The Capital Partnership 1 to 10 2020
NovaGo Therapeutics NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke. Biotech Schlieren, Switzerland Series B $29.7M 2026-08-31 $39.7M Kinled Holding, Pureos Bioventures 1 to 10 2015
Vaderis Therapeutics Vaderis Therapeutics develops targeted therapies for rare vascular diseases in clinical trials. Biotech Basel, Switzerland Series B $152.0M 2026-08-11 $170.6M Medicxi 11 to 50 2019
NVision Quantum Technologies NVision Quantum Technologies develops quantum-based imaging technology that enhances standard MRI systems. Biotech Ulm, Germany Series B $38.0M 2026-05-13 $155.2M Entrée Capital, European Commission, Playground Global +2 101 to 250 2015
Windward Bio Windward Bio develops monoclonal antibodies for advanced immunological diseases. Biotech Basel, Switzerland Series B $165.0M 2026-05-04 $365.0M Qiming Venture Partners, OrbiMed, Novo Holdings +2 11 to 50 2024
Exciva Exciva develops clinical-stage biopharmaceutical therapies for neuropsychiatric symptoms of dementia. Biotech Heidelberg, Germany Series B $59.4M 2026-01-20 $69.8M Andera Partners, LBBW VC, Cure8 Ventures 1 to 10 2015
GlycoEra GlycoEra researches and produces extracellular protein degraders for treating autoimmune diseases. Biotech Wädenswil, Switzerland Series B $130.0M 2025-05-27 $179.3M Sofinnova Partners, Bristol-Myers Squibb, 5AM Ventures +1 11 to 50 2020
Clinomic Clinomic is a medical AI company focused on critical care. Artificial intelligence Aachen, Germany Series B $25.3M 2025-04-08 $54.6M German Federal Ministry of Research, Technology and Space 51 to 100 2019
Noema Pharma Noema Pharma develops therapies that treat disabling symptoms of brain and nervous system conditions. Biotech Basel, Switzerland Series B $147.2M 2024-12-11 $316.5M Polaris Partners, Sofinnova Partners, Invus +2 11 to 50 2019
Aignostics Aignostics is a company that provides AI-powered pathology diagnostics for drug development and clinical research. Artificial intelligence Berlin, Germany Series B $34.0M 2024-10-29 $54.8M HTGF (High-Tech Gruenderfonds), IBB Ventures, Wellington Partners +1 101 to 250 2018
Retinai RetinAI is a company that simplifies clinic, research, and pharmaceutical workflows to improve healthcare. Artificial intelligence Bern, Switzerland Series B $7.8M 2024-10-16 $16.8M Venture Kick, Verve Ventures, Matterwave Ventures 11 to 50 2016
CorFlow Therapeutics CorFlow Therapeutics develops proprietary technologies to diagnose and treat microvascular obstructions. Biotech Baar, Switzerland Series B $48.5M 2024-09-10 $66.1M Innosuisse, Unorthodox Ventures, Panakes Partners +2 11 to 50 2016
iOnctura iOnctura is a clinical-stage biotechnology company developing treatments for cancer. Biotech Geneva, Switzerland Series B $85.7M 2024-06-20 European Innovation Council, M Ventures, VI Partners +2 11 to 50 2017
Hemotune Hemotune develops a therapeutic blood purification platform for treating health conditions. Biotech Schlieren, Switzerland Series B $15.6M 2024-03-25 Venture Kick, Innosuisse, Gebert Rüf Stiftung 11 to 50 2016
Finanzguru Finanzguru is an AI-powered financial assistant that helps users manage their accounts and contracts. Artificial intelligence Frankfurt, Germany Series B $14.2M 2023-04-04 Redstone.VC, seed + speed Ventures, Deutsche Bank +2 51 to 100 2015
Resolve BioSciences Resolve BioSciences conducts biotechnology research in molecular cartography. Biotech Düsseldorf, Germany Series B $71.0M 2022-10-24 $95.0M HTGF (High-Tech Gruenderfonds), EDBI, NRW.BANK +2 51 to 100 2020
Cardior Pharmaceuticals Cardior Pharmaceuticals develops medicines and therapies to treat and prevent heart disease. Biotech Hanover, Germany Series B $75.3M 2021-08-25 HTGF (High-Tech Gruenderfonds), EQT Life Sciences, Bristol-Myers Squibb +2 11 to 50 2016
Aeris Health Aeris Health provides smart solutions for monitoring and improving indoor air quality. Health care Zug, Switzerland Series B $8.5M 2021-03-01 $12.8M PreAngel, Sarona Ventures 11 to 50 2014
Hemovent Hemovent is an emerging medical device company developing new technology. Biotech Aachen, Germany Series B $5.2M 2019-02-14 $13.5M KfW, NRW.BANK, TechVision Fund +2 1 to 10 2013
Amal Therapeutics Amal Therapeutics SA is a privately held Swiss and German biotech startup spun off from the University of Geneva. Biotech Geneva, Switzerland Series B $32.6M 2018-11-12 HTGF (High-Tech Gruenderfonds), Venture Kick, VI Partners +2 11 to 50 2012
Therachon Therachon is a global biotechnology company developing medicines for rare genetic diseases. Biotech Basel, Switzerland Series B $60.0M 2018-08-09 $100.0M Bpifrance, New Enterprise Associates, OrbiMed +2 1 to 10 2014
KB Medical KB Medical is a Swiss company that designs, develops, and commercializes the AQrate robotic system. Hardware Lausanne, Switzerland Series B $2.5M 2016-10-25 Venture Kick, Foundation for Innovation and Technology (FIT), Kinled Holding 1 to 10 2012
Cardiorentis Cardiorentis is a privately owned biopharmaceutical company. Biotech Zug, Switzerland Series B $60.4M 2016-01-10 HealthCare Royalty Partners 1 to 10 2010
Covagen Covagen develops protein-based therapeutics for inflammatory diseases and cancer. Biotech Schlieren, Switzerland Series B $66.1M 2013-12-09 Ventech, Novartis Venture Fund, Andera Partners +2 11 to 50 2007
Mind-NRG Mind-NRG develops peptidic neurotrophic factors for psychiatric and neurologic diseases. Biotech Geneva, Switzerland Series B $7.9M 2013-09-04 Index Ventures, Limburgse Reconversie Maatschappij 1 to 10 2010
Pearltec AG Pearltec provides placement, positioning, and fixation solutions for patients in research imaging studies. Health care Schlieren, Switzerland Series B $2.0M 2012-07-23 Tugboat 1 to 10 2008
Okairos Okairos develops genetic T-cell vaccines, including candidates targeting hepatitis C virus. Biotech Basel, Switzerland Series B $20.5M 2010-09-14 $30.1M EQT Life Sciences, Versant Ventures, Novartis Venture Fund +2 1 to 10 2007
ESBATech ESBATech develops fully human antibody fragments for therapeutic applications using the single-chain antibody framework. Biotech Schlieren, Switzerland Series B $22.0M 2008-08-07 Novartis Venture Fund, VI Partners, SV Health Investors +2 51 to 100 1998
Vivendy Therapeutics Vivendy Therapeutics develops enzyme replacement therapies. Biotech Basel, Switzerland Series B $30.5M 2008-06-23 EQT Life Sciences, BioMedPartners, TVM Capital +1 11 to 50 2006
PregLem PregLem is a Swiss biopharmaceutical company that develops and commercializes new drugs. Biotech Geneva, Switzerland Series B $32.2M 2007-12-04 $58.2M Sofinnova Partners, Sofinnova Investments, MVM Life Science Partners +1 11 to 50 2006

Table 1. Health care startups that raised Series B in DACH: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 103.

Largest rounds

Last 12 months
# Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
1 Windward Bio Windward Bio develops monoclonal antibodies for advanced immunological diseases. Biotech Basel, Switzerland Series B $165.0M 2026-05-04 $365.0M Qiming Venture Partners, OrbiMed, Novo Holdings +2 11 to 50 2024
2 Laza Medical Laza Medical produces AI-powered robotic imaging systems for cardiovascular treatments. Artificial intelligence Pfaffikon, Switzerland Series B $160.0M 2026-11-04 $196.0M Page One Ventures, Unorthodox Ventures, The Capital Partnership 1 to 10 2020
3 Vaderis Therapeutics Vaderis Therapeutics develops targeted therapies for rare vascular diseases in clinical trials. Biotech Basel, Switzerland Series B $152.0M 2026-08-11 $170.6M Medicxi 11 to 50 2019
4 Exciva Exciva develops clinical-stage biopharmaceutical therapies for neuropsychiatric symptoms of dementia. Biotech Heidelberg, Germany Series B $59.4M 2026-01-20 $69.8M Andera Partners, LBBW VC, Cure8 Ventures 1 to 10 2015
5 NVision Quantum Technologies NVision Quantum Technologies develops quantum-based imaging technology that enhances standard MRI systems. Biotech Ulm, Germany Series B $38.0M 2026-05-13 $155.2M Entrée Capital, European Commission, Playground Global +2 101 to 250 2015
6 NovaGo Therapeutics NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke. Biotech Schlieren, Switzerland Series B $29.7M 2026-08-31 $39.7M Kinled Holding, Pureos Bioventures 1 to 10 2015

Table 2. Health care startups that raised Series B in DACH: the 6 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 HTGF (High-Tech Gruenderfonds) Venture capital firm Bonn, Germany 13 13%
2 Venture Kick Startup incubator Schlieren, Switzerland 8 8%
3 Andera Partners Private equity firm Paris, France 4 4% 1 Exciva
4 Boehringer Ingelheim Venture Fund Corporate venture arm Ingelheim Am Rhein, Germany 4 4%
5 Verve Ventures Venture capital firm Zug, Switzerland 4 4%
6 Innosuisse Government investment office Berne, Switzerland 4 4%
7 VI Partners Venture capital firm Altendorf, Switzerland 4 4%
8 NRW.BANK Government investment office Düsseldorf, Germany 4 4%
9 German Federal Ministry of Research, Technology and Space Government investment office Bonn, Germany 3 3% 1 NVision Quantum Technologies
10 Sofinnova Partners Venture capital firm Paris, France 3 3%
11 Forbion Capital Partners Private equity firm Naarden, The Netherlands 3 3%
12 EQT Life Sciences Private equity firm Amsterdam, The Netherlands 3 3%
13 BioMedPartners Venture capital firm Basel, Switzerland 3 3%
14 Novartis Venture Fund Corporate venture arm Basel, Switzerland 3 3%
15 Unorthodox Ventures Family office Austin, United States 2 2% 1 Laza Medical

Table 3. Health care startups that raised Series B in DACH: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Biotech 53 51% $2.1B
Software 16 16% $589.9M
Artificial intelligence 8 8% $572.7M
Hardware 5 5% $61.0M
Fintech 2 2% $72.2M
Commerce 2 2% $8.5M
Energy 1 1% $33.9M
Education 1 1%

Table 4. Health care startups that raised Series B in DACH by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series B 103 100% $20.0M

Table 5. Health care startups that raised Series B in DACH by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Countries

CountriesCompaniesShare
Switzerland 51 50%
Germany 50 49%
Austria 2 2%

Table 6. Health care startups that raised Series B in DACH by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Berlin 14 14%
Basel 8 8%
Munich 8 8%
Zürich 6 6%
Schlieren 5 5%
Lausanne 4 4%
Geneva 4 4%
Frankfurt 4 4%
Heidelberg 3 3%
Zug 3 3%
Neuchâtel 2 2%
Aachen 2 2%

Table 7. Health care startups that raised Series B in DACH by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 1 9% $160.0M
August 2026 2 18% $181.7M
July 2026 2 18% $38.0M
June 2026 1 9% $50.0M
May 2026 3 27% $236.6M
April 2026 1 9% $17.6M
January 2026 1 9% $59.4M

Table 8. Health care startups that raised Series B in DACH: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 11 11% $743.3M
2025 6 6% $282.8M
2024 10 10% $511.2M
2023 3 3% $19.3M
2022 11 11% $256.7M
2021 10 10% $342.3M

Table 9. Health care startups that raised Series B in DACH by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 1 1%
2020 to 2022 12 12%
2015 to 2019 35 34%
2010 to 2014 28 27%
Before 2010 27 26%

Table 10. Health care startups that raised Series B in DACH by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 25 24%
11 to 50 48 47%
51 to 100 15 15%
101 to 250 10 10%
251 to 500 4 4%
1,001 to 5,000 1 1%

Table 11. Health care startups that raised Series B in DACH by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many health care startups in DACH whose last round is Series B are on the list?
103, in the file dated 16 November 2026. 11 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 103 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Health care startups that raised Series B in DACH: 103 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Health care at other stages in DACH

Other sectors that raised Series B in DACH

Cite: FundingWatcher, 103 health care companies in DACH whose most recent round is Series B, 16 November 2026. https://fundingwatcher.com/startups/health-care/series-b/dach/